Showing 1 - 8 results of 8 for search 'Joshua C Cyktor', query time: 0.04s Refine Results
  1. 1
    Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir

    Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir by Madhu C. Choudhary, Joshua C. Cyktor, Sharon A. Riddler

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection.

    Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection. by Joshua C Cyktor, Bridget Carruthers, Gillian L Beamer, Joanne Turner

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART.

    Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART. by John K Bui, Joshua C Cyktor, Elizabeth Fyne, Shalyn Campellone, Stephen W Mason, John W Mellors

    Published 2019-01-01
    Get full text
    Article
  4. 4
    Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy

    Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy by Melissa A. Tosiano, Hanna Mar, Dianna Hoeth, Joseph J. Eron, Rajesh T. Gandhi, Deborah K. McMahon, Ronald J. Bosch, John W. Mellors, Joshua C. Cyktor

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.

    Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. by Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, Christina M Lalama, Joshua C Cyktor, Bernard J Macatangay, Charles R Rinaldo, Sharon A Riddler, Evelyn Hogg, Catherine Godfrey, Ann C Collier, Joseph J Eron, John W Mellors, ACTG A5321 Team

    Published 2017-04-01
    Get full text
    Article
  6. 6
    The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells

    The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells by Dennis C. Copertino Jr., Carissa S. Holmberg, Jared Weiler, Adam R. Ward, J. Natalie Howard, Callie Levinger, Alina P.S. Pang, Michael J. Corley, Friederike Dündar, Paul Zumbo, Doron Betel, Rajesh T. Gandhi, Deborah K. McMahon, Ronald J. Bosch, Noemi Linden, Bernard J. Macatangay, Joshua C. Cyktor, Joseph J. Eron, John W. Mellors, Colin Kovacs, Erika Benko, Alberto Bosque, R. Brad Jones, for the AIDS Clinical Trials Group (ACTG) A5321 Team

    Published 2023-09-01
    Get full text
    Article
  7. 7
    HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy

    HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy by Eva M. Stevenson, Adam R. Ward, Ronald Truong, Allison S. Thomas, Szu-Han Huang, Thomas R. Dilling, Sandra Terry, John K. Bui, Talia M. Mota, Ali Danesh, Guinevere Q. Lee, Andrea Gramatica, Pragya Khadka, Winiffer D. Conce Alberto, Rajesh T. Gandhi, Deborah K. McMahon, Christina M. Lalama, Ronald J. Bosch, Bernard Macatangay, Joshua C. Cyktor, Joseph J. Eron, John W. Mellors, R. Brad Jones, for the AIDS Clinical Trials Group A5321 Team

    Published 2021-02-01
    Get full text
    Article
  8. 8
    Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients

    Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients by Geoffrey T. Ivison, Geoffrey T. Ivison, Geoffrey T. Ivison, Elena Vendrame, Giovanny J. Martínez-Colón, Thanmayi Ranganath, Rosemary Vergara, Nancy Q. Zhao, Nancy Q. Zhao, Maureen P. Martin, Maureen P. Martin, Sean C. Bendall, Mary Carrington, Mary Carrington, Mary Carrington, Joshua C. Cyktor, Deborah K. McMahon, Deborah K. McMahon, Joseph Eron, R. Brad Jones, John W. Mellors, Ronald J. Bosch, Rajesh T. Gandhi, Rajesh T. Gandhi, Susan Holmes, Catherine A. Blish, Catherine A. Blish, The ACTG 5321 Team

    Published 2022-02-01
    Get full text
    Article

Search Tools: